Portfolio company
myBiometry
United States · £2.8m raised
Raised
£2.8m
Latest stage
Seed
Rounds recorded
1
Backed by
2 investors
Sectors
About
This company develops a remote monitoring platform and breath sensor for patients with asthma and COPD to predict and prevent respiratory attacks at home.
SourceFunding history · 1
Similar companies
BPCOmedia
This company develops a remote monitoring platform using artificial intelligence to predict and prevent respiratory exacerbations for patients with chronic obstructive pulmonary disease.
Aflo
This company develops a sensor and app for people with asthma or COPD to improve inhaler technique and enable remote monitoring.
BREATHMENT
This digital health platform provides AI-powered respiratory therapy apps and remote monitoring software for patients with chronic lung conditions and healthcare providers.
Spire Health
This company develops wearable sensors that monitor respiratory patterns and activity to provide remote patient care for individuals with chronic lung diseases.
Inofab Health
This company develops digital spirometers and remote monitoring software for patients with respiratory conditions and healthcare professionals in clinical or home settings.
Aflo Analytics
This company develops a digital platform and connected sensor that monitors inhaler technique and adherence for patients with respiratory conditions and their clinicians.
BREATHER ONE
This company develops a portable medical device and gamified software system for the respiratory rehabilitation of patients with asthma and chronic lung conditions.
Apieron
This company develops biosensor devices to monitor exhaled nitric oxide for asthma management in patients and clinical settings.
